Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. is a member of the listed company "Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd." (listed in Hong Kong H shares and Shanghai A shares) controlled by Guangzhou Pharmaceutical Group. Its predecessor was founded in 1950. In 2018, the Guangzhou Xingqun Traditional Chinese Medicine Refinery, which was the first in China to carry out modernization of traditional Chinese medicine, can be traced back to Huang Xianghua Pharmaceutical Factory in 1868. After years of continuous innovation and development, it has become a large dosage form of granules, soft capsules, oral solutions, liniments, tinctures, syrup, etc., with more than 600 employees, annual sales of nearly 500 million yuan, and annual profit tax exceeding the annual profit tax. A modern pharmaceutical and health enterprise with RMB 60 million. In recent years, it has won the honors of China Customs Trusted Enterprise, National Quality Management Award, National High-tech Enterprise, National Contract-Based and Trustworthy Enterprise, and National Intellectual Property Advantage Enterprise.

The company has always adhered to the corporate mission of "Health Star, Caring for the People", caring for the health of the public, promoting household medicines, fulfilling social responsibilities, pursuing excellent quality, and creating a trusted brand. The company's main representative products include: Xiasangju Granules, Ertian Oil, Pediatric Aminophen Huangnamin Granules, Anshen Bu Brain Liquid, as well as Alpha Calcium Capsules, Compound Licorice Oral Solution, Vitamin E Soft Capsules, etc. The products are sold nationwide. Exported to America, Southeast Asia and other regions.

Baiyun Mountain Star Qun Xia Sangju has been trusted by consumers for many years. After nearly 40 years of large-scale and modern production, the cumulative sales have exceeded 11 billion small parcels, benefiting 11 billion people at home and abroad, and the average annual sales revenue of the product has reached 200 million yuan. Xingqun Company has always insisted on inheriting the essence and upholding the truth and innovating. While vigorously developing its main pharmaceutical business, it has actively entered the pharmaceutical and health industry. It has successively launched a series of big health products such as food, mineral water, health products, pharmaceutical cosmetics, and healthy beverages. Market recognition and welcome.

The company currently has 4 national, provincial and municipal R&D platforms, including Guangdong Provincial Enterprise Technology Center, Guangdong Traditional Chinese Medicine Drop Engineering Technology Research Center, Guangzhou Municipal Enterprise Technology Center, Guangzhou Enterprise Research and Development Institution (Children). medicine direction). The company has successively introduced a number of production equipment and testing instruments with international advanced level, with fully automatic particle manufacturing and packaging equipment, soft capsule manufacturing equipment, hard capsule filling equipment, liquid infusion equipment, capsule packaging equipment and high-performance liquid chromatographs, etc. Advanced equipment.

Baiyunshan Xingqun Company has a glorious historical tradition of innovation. At a time when New China is in a state of incomplete development, it pioneered the modernization of traditional Chinese medicine, started the country's traditional Chinese medicine refining agents and plant medicine purification, and pioneered the country's first suppression method to prepare soft capsules. It was the first to develop a successful granule powder, which has cultivated excellent innovative and creative genes and continuously led the development of traditional Chinese medicine culture.

Looking to the future, Xingqun people are committed to building a modern enterprise with global passion and fighting spirit, with unique characteristics and distinct cultures for traditional Chinese medicine. They take it as their mission to revitalize the national pharmaceutical industry and strive to contribute to the revitalization and development of the traditional Chinese medicine health industry. .